LGD 3303

CAS: 917891-35-1

Ref. 3D-FL102146

Produktinformation

• Name: LGD 3303

Beschreibung

LGD 3303 is a selective estrogen receptor modulator that has been shown to have therapeutic potential for the treatment of metabolic disorders and cancer. LGD 3303 binds to the estrogen receptor alpha (ERα) and beta (ERβ), which has been shown to inhibit the proliferation of human breast cancer cells in vitro. It also inhibits adipose tissue growth, increases bone growth, and improves blood pressure regulation. LGD 3303 has been shown to have beneficial effects on metabolic disorders such as insulin resistance, obesity, and diabetes. This drug may also be able to treat inflammatory diseases such as arthritis or skin conditions like atopic dermatitis in animals.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 342.74 g/mol
• Formel: C₁₆H₁₄ClF₃N₂O
• Reinheit: Min. 95%
• Farbe/Form: Powder